Login / Signup

Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease.

Seiko IshikawaShotaro NaitoSoichiro IimoriDaiei TakahashiMoko ZeniyaHidehiko SatoNaohiro NomuraEisei SoharaTomokazu OkadoShinichi UchidaTatemitsu Rai
Published in: PloS one (2018)
In our cohort, the prevalence of sarcopenia in patients with NDD-CKD was high, and diuretics use, particularly loop diuretic use, was suggested to be a risk factor of sarcopenia. Although loop diuretics are commonly used in patients with CKD, careful consideration of the risk of sarcopenia may be necessary.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • skeletal muscle
  • risk factors
  • community dwelling
  • transcription factor
  • heart failure
  • peritoneal dialysis
  • atrial fibrillation